The Royal Society and the US National Academies of Sciences and Medicine are convening an international commission to develop a framework for considering technical, scientific, medical, regulatory, and ethical requirements for human germline genome editing, should society conclude such applications are acceptable.
To inform its deliberations, the Commission is engaging with external expertise and has launched a call for evidence, open until Friday 27 September 2019. The Commission would welcome the circulation of this call to members of the Royal Society of New Zealand, and would very much appreciate their input.
Several question in the call invite broad input, while others are more technical in nature. Respondents are encouraged to address those questions most relevant to their particular area(s) of expertise. When appropriate, providing citations and/or links to evidence in support of their responses is greatly appreciated.
The U.S. National Academies will list all written submissions in a Public Access File (PAF) established for the International Commission. These submissions will be made available to the public upon request. If members prefer that personally identifiable details not be included in the PAF, they must not include their name, contact information, or other such specifics in their comments.
Thank you very much in advance for your time circulating this call, and the Commission looks forward to receiving members’ responses.